PLX3397, Radiation Therapy, and Antihormone Therapy in Treating Patients With Intermediate- or High-Risk Prostate Cancer

Clinical trial NCT02472275 · COMPLETED

Trial details

NCT number: NCT02472275
Sponsor: Barbara Ann Karmanos Cancer Institute
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Stage I Prostate Adenocarcinoma Stage II Prostate Adenocarcinoma Stage III Prostate Adenocarcinoma

Start date: 2015-06-01
Primary completion: 2019-08-05
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.